Table 3 Overall survival rates of patients
Cancer type | No | Overall survival rates (%) | HR (95% CI) | p a | ||
|---|---|---|---|---|---|---|
1-year (95% CI) | 2-year (95% CI) | 3-year (95% CI) | ||||
Whole cohort | 9235 | 36.7(36.6–36.7) | 18.7(18.6–18.7) | 11.7(11.6–11.7) | ||
Without prior cancer | 8797 | 36.8(36.7–36.9) | 18.7(18.6–18.8) | 11.7(11.6–11.8) | ||
Prostate cancer | 126 | 35.6(35.3–35.8) | 21.4(21.1–21.5) | 13.3(13.1–13.5) | 1.137(0.928–1.393) | 0.171 |
Breast cancer | 110 | 36.5(36.4–36.6) | 16.6(16.5–16.7) | 14.7 (14.6–14.8) | 0.966(0.780–1.197) | 0.749 |
Renal and bladder cancer | 51 | 35.6(35.5–35.7) | 21.4(21.3–21.5) | 13.3(13.2–13.4) | 1.004(0.732–1.376) | 0.980 |
Colon and rectal cancer | 43 | 30.2(30.1–30.3) | 15.3(15.2–15.4) | 12.3(12.2–12.4) | 1.149(0.813–1.624) | 0.382 |
Uterine cancer | 24 | 41.8(41.6–42.0) | 36.6(36.4–36.8) | 36.6(36.4–36.8) | 0.700(0.451–1.086) | 0.165 |
Lung cancer | 16 | 49.2(49.0–49.4) | 16.4(16.2–16.6) | 8.2(8.1–8.4) | 0.865(0.531–1.408) | 0.572 |
Small intestinal cancer | 15 | 44.0(43.7–44.3) | 11.7(11.5–11.9) | 11.7(11.5–11.9) | 0.948(0.533–1.687) | 0.855 |
Oral cancer | 13 | 51.9(51.6–52.2) | 17.3(17.1–17.5) | 0.0 | 0.976(0.544–1.752) | 0.935 |
Gastric cancer | 12 | 36.5(36.2–36.8) | 0.0 | 0.0 | 1.150(0.571–2.318) | 0.663 |
Hepatocellular cancer | 8 | 37.5(37.2–37.8) | 12.5(12.3–12.7) | 12.5(12.3–12.7) | 1.014(0.481–2.138) | 0.971 |
Matched cohort | 4818 | 35.1(35.0–35.2) | 18.2(18.1–18.2) | 11.7(11.7–11.7) | ||
Without prior cancer | 4380 | 33.0(32.9–33.1) | 18.2(18.1–18.3) | 11.7(11.6–11.7) | ||
Prostate cancer | 126 | 35.6(35.3–35.5) | 21.4(21.1–21.5) | 13.3(13.1–13.5) | 0.967(0.708–1.318) | 0.826 |
Breast cancer | 110 | 36.5(36.4–36.6) | 16.6(16.5–16.7) | 14. (14.6–14.8) | 0.927(0.751–1.145) | 0.481 |
Renal and bladder cancer | 51 | 35.6(35.5–35.7) | 21.4(21.3–21.5) | 13.3(13.2–13.4) | 0.967(0.709–1.318) | 0.826 |
Colon and rectal cancer | 43 | 30.2(30.1–30.3) | 15.3(15.2–15.4) | 12.3(12.2–12.4) | 1.107(0.788–1.557) | 0.521 |
Uterine cancer | 24 | 41.8(41.6–42.0) | 36.6(36.4–36.8) | 36.6(36.4–36.8) | 0.676(0.439–1.041) | 0.125 |
Lung cancer | 16 | 49.2(49.0–49.4) | 16.4(16.2–16.6) | 8.2(8.048–8.352) | 0.842(0.520–1.364) | 0.504 |
Small intestinal cancer | 15 | 44.0(43.7–44.3) | 11.7(11.5–11.9) | 11.7(11.5–11.9) | 0.908(0.517–1.596) | 0.739 |
Oral cancer | 13 | 51.9(51.6–52.2) | 17.3(17.1–17.5) | 0.0 | 0.943(0.531–1.676) | 0.840 |
Gastric cancer | 12 | 36.5(36.2–36.8) | 0.00 | 0.0 | 1.093(0.552–2.167) | 0.781 |
Hepatocellular cancer | 8 | 37.5(37.2–37.8) | 12.5(12.3–12.7) | 12.5(12.3–12.7) | 0.982(0.471–2.010) | 0.961 |